Skye Bioscience Inc (SKYE) FY2025Q1 Earning Prediction

05/08 04:00:00

After Hours

Skye Bioscience Inc (SKYE) is set to release its earnings performance on 05/08 04:00:00 in After Hours trading. Consensus forecasts predict a revenue of - and an earnings per share (EPS) of -0.31 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!

Estimate

Actual

Surprise

Revenue-

0.00

EPSBEAT

-0.31

-0.28

+9.68%

AI Summary

Attend Webcast

Earnings Surprise Analysis

The chart displays the extent of earnings surprises and corresponding stock price movements for each earnings event.

Revenue

EPS

SKYE Transcript

Skye Bioscience, Inc. (SKYE) Q3 2025 Earnings Call Transcript

Unknown11-10

The earnings call reveals mixed signals. Financial performance shows increased R&D expenses and a larger net loss, but cash reserves are solid. Product development is promising, with positive feedback on Nimacimab and its potential in obesity treatment. However, uncertainties remain, particularly regarding weight regain issues and the need for higher dosing. The Q&A session highlighted optimism about future trials but also exposed gaps in understanding current data. Overall, the financial health and product prospects balance out, leading to a neutral sentiment.

Skye Bioscience, Inc. (SKYE) CBeyond Phase 2a Clinical Trial Topline Data Conference Call Transcript

Neutral10-6

Skye Bioscience, Inc. (SKYE) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Neutral9-10

Skye Bioscience, Inc. (SKYE) Q2 2025 Earnings Call Transcript

Unknown8-7

The earnings call reveals several concerns: rising R&D expenses, significant net losses, and execution risks in scaling manufacturing. Although nimacimab shows potential, management's vague responses and strategic risks highlight uncertainties. Despite adequate funding, the financial health appears strained. The market may react negatively due to increased losses and unclear guidance on nimacimab's efficacy, outweighing any optimism from ongoing trials.

SKYE Slides

Skye Bioscience Q2 2025 slides: Nimacimab targets obesity treatment gaps

2025-08-07

SKYE Report

Skye Bioscience, Inc. 10-Q

10-Q

2024-11-07

Frequently Asked Questions

What is the Skye Bioscience Inc FY2025Q1 Earnings Release Date and Time?

Skye Bioscience Inc (SKYE) is scheduled to release its FY2025Q1 earnings report onMay 8, 2025, After Hours(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.

What Are the Consensus Forecasts for Skye Bioscience Inc FY2025Q1 Revenue and EPS?

Analysts' consensus predicts 0.00 in revenue and an EPS of -0.31 for Skye Bioscience Inc's FY2025Q1.

What Does Intellectia's AI Predict for Skye Bioscience Inc FY2025Q1 Earnings?

Intellectia's exclusive AI algorithms forecast a forSkye Bioscience Inc's FY2025Q1 earnings, with a prediction date of May 8, 2025. Skye Bioscience Inc

How Can I Use This Earnings Prediction to Trade SKYE Stock?

Leverage Intellectia's AI forecast to position trades ahead of theMay 8, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.

How Accurate Is Intellectia's AI for Earnings Predictions Like Skye Bioscience Inc FY2025Q1?

Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.

How does AI Earnings Prediction generate its forecasts?

AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!

When are the predictions available, and how often are they updated?

Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.

Can I use AI Earnings Prediction for all types of stocks?

Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!